Truist Financial analyst Jailendra Singh maintains $IQVIA Holdings (IQV.US)$ with a buy rating, and sets the target price at $265.
According to TipRanks data, the analyst has a success rate of 27.5% and a total average return of -17.7% over the past year.
Furthermore, according to the comprehensive report, the opinions of $IQVIA Holdings (IQV.US)$'s main analysts recently are as follows:
Iqvia's third quarter performance surpassed expectations primarily due to its TAS segment's impressive results. However, this success is currently overshadowed by challenges faced within the R&DS area, including a significant project cancellation and the postponement of two major trials until 2025. Despite these headwinds, the perceived value versus risk remains compelling following the stock's recent decline.
The company indicated that the market remains relatively stable, highlighting that the challenges with bookings are arising from delays and drug failures, rather than significant effects from pipeline rationalization.
The company has encountered a challenging industry operating environment. Comments from the company indicate that pharma portfolio reprioritizations related to the IRA may be concluding, and the company seems to be gaining from the pharmaceutical industry's vendor consolidation trend.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
